|
 |
| ©2004-2008, Quantum Laboratories,
Inc.. All rights reserved.
|
|
|
|
|
|
|
|
|
Panic
Disorders in Adolescents
•
Protocol A6131002: A Randomized, double blind, placebo-controlled
study of Xanax XR in the treatment of adolescents with a
primary diagnosis of Panic Disorder.
•
Protocol A 6131004: An open label study to asses the safety
and tolerance of Xanax XR in the treatment of adolescents
with panic disorder or anxiety with panic attacks.
•
Protocol A6131007: A Randomized, double blind, placebo-controlled
study of continuation treatment with Xanax XR in the treatment
of adolescents with a primary diagnosis of Panic Disorder.
For
more information please call (561) 687-2111
|
|
|
|
|
|
|
Our facility identifies and recruits appropriate patients and
monitors them during the study. If you qualify and consent to
participate, there will be no charge for your study medication
and office visits. Additionally, you are responsible for attendence
to regular scheduled appointments.
|
|
|
|
|
Fact:
During any one-year period, up to 50 million Americans suffer
from clearly diagnosable mental disorder involving a degree
of incapacity that interferes with employment, attendence at
school or daily life.
|
|
|
|
